References
- DERK C.T., JIMENEZ S.A. Systemic sclerosis: current views of its pathogenesis. Autoimmun. Rev. 2003; 2:181–191
- HERRICK A.L., MATUCCI CERINIC M. The emerging problem of oxidative stress and the role of antioxidants in systemic sclerosis. Clin. Exp. Rheumatol. 2001; 19:4–8
- ASSASSI S., MAYES M.D., ARNETT F.C., GOURH P., AGARWAL S.K., MCNEARNEY T.A., et al. Systemic sclerosis and lupus: Points in an interferon‐mediated continuum. Arthritis Rheum. 2010; 62:589–598
- DOMSIC R.T. Scleroderma. Curr. Opin. Rheumatol. 2014; 26:646–652
- SMITH V., DECUMAN S., SULLI A., BONROY C., PIETTTE Y., DESCHEPPER E., et al. Do worsening scleroderma capillaroscopic patterns predict future severe organ involvement? a pilot study. Ann. Rheum. Dis. 2012; 71:1636–1639
- ELSAYED A.M., ELHEFNY A.M., ABOGABAL M.M., MOBASHER S.A., ABDELZAHER A., ALHASSANEIN K.F., et al. Progressive systemic sclerosis in Egyptian patients: Clinical characteristics and nail fold capillaroscopy. Egypt. Rheumatol. 2019; 41:47–51
- MEIJS J., SCHOUFFOER A.A., AJMONE MARSAN N., KROFT L.J.M., STIJNEN T., NINABER M.K., et al. Therapeutic and diagnostic outcomes of a standardised, comprehensive care pathway for patients with systemic sclerosis. RMD Open 2016; 2:e000159
- PRESTON I.R., HILL N.S. Evaluation and management of pulmonary hypertension in systemic sclerosis. Curr. Opin. Rheumatol. 2003; 15:761–765
- BEHR J., VOGELMEIER C., BEINERT T., MEURER M., KROMBACH F., KÖNIG G., et al. Bronchoalveolar lavage for evaluation and management of scleroderma disease of the lung. Am. J. Respir. Crit. Care Med. 1996; 154:400–406
- TYNDALL A.J., BANNERT B., VONK M., AIRO P., COZZI F., CARREIRA P.E., et al. Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database. Ann. Rheum. Dis. 2010; 69:1809–1815
- MUKERJEE D. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann. Rheum. Dis. 2003; 62:1088–1093
- DEMEROUTI E., TSANGARIS I., DIMITROULAS T., GIANNAKOULAS G., KATSIMPRI P., MITROUSKA I., et al. Pulmonary Arterial Hypertension in Connective Tissue Disorders: The emerging role of screening and early diagnosis. A position paper for Greek Rheumatologists. Mediterr. J. Rheumatol. 2019; 30:90–93
- INGEGNOLI F., ARDOINO I., BORACCHI P., CUTOLO M., AIRÒ P., ANANIEVA L.P., et al. Nailfold capillaroscopy in systemic sclerosis: Data from the EULAR scleroderma trials and research (EUSTAR) database. Microvasc. Res. 2013; 89:122–128
- HERRICK A.L., CUTOLO M. Clinical implications from capillaroscopic analysis in patients with Raynaud’s phenomenon and systemic sclerosis. Arthritis Rheum. 2010; 62:2595–2604
- VAN DEN HOOGEN F., KHANNA D., FRANSEN J., JOHNSON S.R., BARON M., TYNDALL A., et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology/European league against rheumatism collaborative initiative. Ann. Rheum. Dis. 2013; 72:1747–1755
- VASILE M., AVOUAC J., SCIARRA I., STEFANANTONI K., IANNACE N., CRAVOTTO E., et al. From VEDOSS to established systemic sclerosis diagnosis according to ACR/EULAR 2013 classification criteria: a French-Italian capillaroscopic survey. Clin. Exp. Rheumatol. 2018; 36 Suppl 1:82–87
- CUTOLO M., MELSENS K., WIJNANT S., INGEGNOLI F., THEVISSEN K., DE KEYSER F., et al. Nailfold capillaroscopy in systemic lupus erythematosus: A systematic review and critical appraisal. Autoimmun. Rev. 2018; 17:344–352
- MEDSGER T.A., BOMBARDIERI S., CZIRJAK L., SCORZA R., DELLA ROSSA A., BENCIVELLI W. Assessment of disease severity and prognosis. Clin. Exp. Rheumatol. 2003; 21:S42-6
- INSTITUTE OF MEDICINE OF THE NATIONAL ACADEMIES. Cardiovascular Disability: Updating the Social Security Listings, The National Academies Press, Washington, DC, 2010
- PATTANAIK D., BROWN M., POSTLETHWAITE B.C., POSTLETHWAITE A.E. Pathogenesis of Systemic Sclerosis. Front. Immunol. 2015; 6:272
- CUTOLO M., SULLI A., SMITH V. How to perform and interpret capillaroscopy. Best Pract. Res. Clin. Rheumatol. 2013; 27:237–248
- SULLI A., PIZZORNI C., SMITH V., ZAMPOGNA G., RAVERA F., CUTOLO M. Timing of transition between capillaroscopic patterns in systemic sclerosis. Arthritis Rheum. 2012; 64:821–825
- MOORE D.F., STEEN V.D. Overall mortality. J. Scleroderma Relat. Disord. 2021; 6:3–10
- WALKER U.A., TYNDALL A., CZIRJAK L., DENTON C., FARGE-BANCEL D., KOWAL-BIELECKA O., et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann. Rheum. Dis. 2007; 66:754–763
- RAHAGHI F.F., HSU V.M., KANER R.J., MAYES M.D., ROSAS I.O., SAGGAR R., et al. Expert consensus on the management of systemic sclerosis-associated interstitial lung disease. Respir. Res. 2023; 24:6
- COGHLAN J.G., DENTON C.P., GRÜNIG E., BONDERMAN D., DISTLER O., KHANNA D., et al. Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study. Ann. Rheum. Dis. 2014; 73:1340–1349
- VOLKMANN E.R., FISCHER A. Update on morbidity and mortality in systemic sclerosis–related interstitial lung disease. J. Scleroderma Relat. Disord. 2021; 6:11–20
- GUALTIEROTTI R., INGEGNOLI F., GRIFFINI S., GROVETTI E., BORGHI M.O., BUCCIARELLI P., et al. Detection of early endothelial damage in patients with Raynaud’s phenomenon. Microvasc. Res. 2017; 113:22–28
- CESTELLI V., MANFREDI A., SEBASTIANI M., PRAINO E., CANNARILE F., GIUGGIOLI D., et al. Effect of treatment with iloprost with or without bosentan on nailfold videocapillaroscopic alterations in patients with systemic sclerosis. Mod. Rheumatol. 2017; 27:110–114